TRCT
AMIX

Tower Research Capital (TRC)’s Autonomix Medical AMIX Stock Holding History

Tower Research Capital (TRC)’s Portfolio AMIX Stock Details AMIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95K Buy
313
+35
+13% +$274 ﹤0.01% 4742
2026
Q1 		$2.28K Sell
278
-1
-0.4% -$9 ﹤0.01% 4503
2025
Q4 		$3.22K Buy
279
+25
+10% +$485 ﹤0.01% 4404
2025
Q3 		$5.77K Buy
254
+120
+90% +$3.14K ﹤0.01% 4202
2025
Q2 		$4.4K Buy
134
+31
+30% +$1.11K ﹤0.01% 4333
2025
Q1 		$3.8K Buy
103
+59
+134% +$3.26K ﹤0.01% 4349
2024
Q4 		$3.46K Buy
44
+32
+267% +$5.66K ﹤0.01% 4651
2024
Q3 		$3.01K Sell
12
-7
-37% -$2.35K ﹤0.01% 4909
2024
Q2 		$7.68K Buy
19
+15
+375% +$14.8K ﹤0.01% 4436
2024
Q1 		$4.55K Buy
+4
New +$6.64K ﹤0.01% 4664

Other funds holding AMIX

Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return
NA
Networth Advisors Canonsburg, Pennsylvania $172M AUM

Tower Research Capital (TRC)'s AMIX Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Autonomix Medical (AMIX) stake by 13% in Q2 2026, buying an estimated $274 and bringing the position to 313 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4742.

Tower Research Capital (TRC) first reported a position in AMIX in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.68K in Q2 2024. 6 funds tracked by Wall St. Rank hold AMIX as of Q2 2026.

  • Tower Research Capital (TRC) held 313 shares of Autonomix Medical worth $1.95K as of Q2 2026.
  • Tower Research Capital (TRC) bought 35 Autonomix Medical shares in Q2 2026, an estimated $274.
  • Autonomix Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4742 holding.
  • Tower Research Capital (TRC) first reported a position in Autonomix Medical in Q1 2024 and has held it in 10 quarters since.
  • Tower Research Capital (TRC)'s Autonomix Medical position peaked at $7.68K in Q2 2024.
  • 6 funds tracked by Wall St. Rank held Autonomix Medical as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.